Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific.

Respiratory research - 1 Jan 2001

Pantelidis P, McGrath D S, Southcott A M, Black C M, du Bois R M

Abstract excerpt

BACKGROUND: Previous studies have revealed that tumour necrosis factor (TNF)-alpha is upregulated in fibrosing alveolitis (FA) in humans. The aim of this study was to compare the TNF-alpha secretory profile of alveolar macrophages (AMs) and peripheral blood monocytes (Mos) of patients with cryptogenic FA and systemic sclerosis (SSc), a rheumatological disorder in which lung fibrosis can occur. In particular, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Cells
Share to Bronchoalveolar Lavage Fluid
Share to Leukocyte Count

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Macrophages, Alveolar

Share to Neutrophils

Share to Phagocytes

Share to Pulmonary Fibrosis

Share to Scleroderma, Systemic

Source

Open in PubMed Open full text

Identifiers

PMID: 11737936
DOI: 10.1186/rr87
PMCID: PMC64804

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumour necrosis factor-alpha production in fibrosing alveolitis is macrophage subset specific.PMID 11737936Read ↗

Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease.Semantic proximity Read ↗

Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease.Semantic proximity Read ↗

Efferocytosis dysfunction in CXCL4-induced M4 macrophages: phenotypic insights in systemic sclerosis in vitro and in vivo.Semantic proximity Read ↗

Profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in systemic sclerosis-associated interstitial lung diseaseSemantic proximity Read ↗

Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis.Semantic proximity Read ↗

Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo study.Semantic proximity Read ↗

Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis.Semantic proximity Read ↗

Lupus patients with pulmonary involvement have a pro-inflammatory cytokines profile.Semantic proximity Read ↗

Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis.Semantic proximity Read ↗

Immunoglobulin G of systemic sclerosis patients programs a pro-inflammatory and profibrotic phenotype in monocyte-like THP-1 cells.Semantic proximity Read ↗

Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source.Semantic proximity Read ↗

Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.